Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 73 for “"Glibenclamide"”.
-
Comparison of different therapies for neonatal diabetes – glibenclamide vs insulin
… implanted with insulin pellets or a high-dose glibenclamide pellet. Insulin therapy restored blood glucose levels but failed to fully preserve pancreatic islet and β-cell morphology and function. Conversely, glibenclamide therapy reduced elevated blood glucose concentrations down to a …
-
Vascular effects of K ATP channel blockade by glibenclamide in humans
KUN, 04 februari 2002
-
Vaistinio junginio glibenklamido BMR parametrų modeliavimas vandeniniuose bioaktyvių joninių skysčių tirpaluose /
Glibenclamide also known as gliburide is a sulphonylurea drug used to treat type 2 diabetes. Glibenclamide's mechanism of action is based on inhibiting membrane adenosine triphosphate (ATP) sensitive potassium ion channels (K_ATP) in liver cells, thus controling insulin secretion and glucose levels …
-
Effect of oral hypoglycaemic agents on placental ABC transporter expression and activity
… metformin) and sulphonylureas (for example glibenclamide, also known as glyburide). In the placenta a network of apical ATP-binding cassette (ABC) transporters facilitates the efflux of substances away from the fetus, thereby protecting the fetus from exposure to unwanted substances …
-
The relationship between potassium(ATP) channels and energy state in skeletal muscle during fatigue development
… activity was abolished pharmacologically using glibenclamide or genetically using Kir6.2-/- FDB muscle bundles; pinacidil was used to activate the channel. Abolishing KATP channel activity had no effect on the decrease in phosphocreatine (PCr), but pinacidil significantly reduced its depletion. …
-
Prescribing patterns of hypoglycaemic drugs in the treatment of Type 2 Diabetes Mellitus in public institutions in Lesotho
… three times, metformin 500 mg three times a day, glibenclamide 10 mg daily and glibenclamide 5 mg twice daily are oral hypoglycaemic agents that were first, second, third and fourth choice treatment of DM at all four study sites at a frequency of 54.2% (n = 160), 27.7% (n = 82), 4% (n = 12) and …
-
The effect of the KATP channel on energy metabolism in skeletal muscle during fatigue
… KATP channels, to the KATP channel blocker, glibenclamide, or the opener, pinacidil, did not affect lactate production during the three min fatigue. However, DMSO, used to dissolve glibenclamide and pinacidil caused a decrease in lactate content during the last two min of fatigue, an effect …
-
Investigating the effect of low-dose sulfonylureas on glucagon secretion in diabetes mellitus
… whether low doses of the sulfonylurea glibenclamide could reduce fasting hyperglucagonaemia in patients with T2DM. In addition, the effect of age and sex on islet hormone secretion was examined in human islets, as was the impact of low-dose gliclazide (another sulfonylurea) on glucagon …
-
Συσχέτιση της μεταγευματικής γλυκαιμίας μη ινσουλινοεξαρτώμενων διαβητικών ασθενών με την ενεργοποίηση της πήξης
… mealIn a second phase we study the action of glibenclamide given once beforethe meal in this activation In a group of similar patients we study also theeffect of glimepindeFinally we studied the effect of glibenclamide on postprandial lipemiaRESULTS Diabetic subjects had higher levels of F1+2 …
-
Investigation of Biochemical Mechanisms Associated with Insulin Resistance in the Non-Insulin-Dependent Diabetes Mellitus
… we have investigated the effect of diazoxide and glibenclamide (another SUR ligand) on glucose transport and insulin signaling in cultured 3T3-L1 adipocytes. Our results suggest that diazoxide has no direct effect on insulin signaling and glucose transport. In contrast, glibenclamide exhibited …
-
Regulation of Myoplasmic Ca2+ During Fatigue in KATP Channel Deficient FDB Muscle Fibres
… i) by exposing wild type muscle fibers to glibenclamide, a KATP channel blocker and ii) by using fibres from Kir6.2-/- mice, which are null mice for the Kir6.2 gene that encodes for the protein forming the channel pore. Verapamil, a L-type Ca2+ channel blocker, applied at 1 μM, …
-
Combinatorial Targeting of the Glucagon-Like Peptide-1 And Sulfonylurea-1 Receptors Using a Complimentary Multivalent Glucagon-Like Peptide-1/Glibenclamide Ligand for the Improvement of β-Cell Targeting Agents and Diabetic Treatment
… glucagon-like peptide-1 (GLP-1) and glibenclamide (Glb), targeted against the GLP-1R and the sulfonylurea-1 receptor (SUR1) is a lead compound for the development of specific bi-functional islet cell targeting agents for use in the in vivo detection and treatment of β -cells. Herein, …
-
Ion currents and proliferation in MCF-7 human breast cancer cells.
… (K) channel antagonists quinidine, linogliride, glibenclamide, 4-aminopyridine (4-AP) and tetraethylammonium (TEA) inhibited MCF-7 cell proliferation. Among those blockers three (quinidine, linogliride and glibenclamide) also produced a reversible G0/G1 arrest. On the basis that these three drugs …
-
Επιδράσεις της ινσουλίνης και των ινσουλινοειδών αυξητικών παραγόντων (IGF) στη διακίνηση του υπεζωκοτικού υγρού στο πρόβατο και στον άνθρωπο
… inhibitors (amiloride, ouabain, L-NAME, glibenclamide) or solutions with low K+, Na+, Ca2+, pH and glucose concentration. Insulin (concentrations ?10-6M) increased RTM within 5 minutes towards the pleural surface (mainly for lower parts). Amiloride and ouabain completely abolished this …
-
Efficacy and mechanism of nicorandil in perioperative protection of skeletal muscle from ischaemia and reperfusion injury in a porcine model
… HMR-1098 or non-specific KATP inhibitor Glibenclamide before Nicorandil injection completely blocked the infarct-protective effects. Injection of the specific mitochondrial KATP (mKATP) inhibitor 5-HD or Glibenclamide before the onset of reperfusion also abolished Nicorandil …
-
Role of cellular ion channels in the BK polyomavirus life cycle
… identified that the clinically available drug, Glibenclamide is a potent inhibitor of BKPyV infection. Biochemical analysis and molecular-based techniques revealed that the cystic fibrosis transmembrane conductance regulator (CFTR) was the target of Glibenclamide and time-of-addition experiments …
-
Biocatalytic Production, Preparation and Characterization of Large-ring Cyclodextrins
… helped to obtain higher solubilization levels of glibenclamide, vitamin A acetate and vitamin D<sub>3</sub> in CD<sub>13</sub>, CD<sub>10</sub> and CD<sub>11</sub>, respectively when compared to other CD. Vitamin K<sub>1</sub> was solubilized in distilled water with CD<sub>6</sub> – …
-
Studies on the stimulant action of human gamma-globulin on spontaneous contractility: interaction with K⁺-channel openers and postaglandin inhibitors
… noradrenaline on the rat mesenteric portal vein. Glibenclamide, a potassium channel antagonist, potentiated the action of human gamma-globulin on the portal vein by 45% and on its own had a biphasic (increase followed by a decrease) effect on the spontaneous activity of the portal vein . …
-
Modulation of neocortical neurotransmissions by antidepressants and neuromodulatory drugs in human and rodent brain tissue and effect of electrical high-frequency stimulation in human neocortex
… neocortical slices. The KATP channel blockade by glibenclamide enhanced the electrically evoked [3H]-5- HT release similarly in rat and in mouse neocortex slices. After short-term blockade (45 min) of 5-HT uptake, glibenclamide still increased the release of [3H]- 5-HT in the rat. Glibenclamide, …
Page 1 of 4